Overview
Ian Krop is an Oncologist in New Haven, Connecticut. Dr. Krop is rated as an Elite provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are HER-2 Positive Breast Cancer, Breast Cancer, Metastatic Brain Tumor, and Inflammatory Breast Cancer.
His clinical research consists of co-authoring 227 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles and participated in 2 clinical trials in the study of HER-2 Positive Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
35 Park St, New Haven, CT 06519
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Yale University
Eric Winer is an Oncologist and a Hematologist Oncology provider in New Haven, Connecticut. Dr. Winer is rated as an Elite provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, and Breast Cancer in Men.
Julie Gold is a Hematologist and an Oncologist in Mount Kisco, New York. Dr. Gold is rated as a Distinguished provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and HER-2 Positive Breast Cancer.
Yale University
Maryam Lustberg is an Oncologist in New Haven, Connecticut. Dr. Lustberg is rated as a Distinguished provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Krop isElite. Learn about Breast Cancer.
- HER-2 Positive Breast Cancer
- Distinguished
- Inflammatory Breast CancerDr. Krop isDistinguished. Learn about Inflammatory Breast Cancer.
- Metastatic Brain TumorDr. Krop isDistinguished. Learn about Metastatic Brain Tumor.
- Advanced
- AngiosarcomaDr. Krop isAdvanced. Learn about Angiosarcoma.
- Breast Cancer in MenDr. Krop isAdvanced. Learn about Breast Cancer in Men.
- Febrile NeutropeniaDr. Krop isAdvanced. Learn about Febrile Neutropenia.
- Paget Disease of the BreastDr. Krop isAdvanced. Learn about Paget Disease of the Breast.
- Experienced
- AgranulocytosisDr. Krop isExperienced. Learn about Agranulocytosis.
- Brain TumorDr. Krop isExperienced. Learn about Brain Tumor.
- Lung CancerDr. Krop isExperienced. Learn about Lung Cancer.
- ThrombocytopeniaDr. Krop isExperienced. Learn about Thrombocytopenia.
- Trophoblastic Tumor Placental SiteDr. Krop isExperienced. Learn about Trophoblastic Tumor Placental Site.